LaJolla Pharmaceutical Company's IPO

LaJolla Pharmaceutical Company raised a round of funding on February 06, 2006. Investors include Public.

Founded in 1989, La Jolla Pharmaceutical Company is a biotechnology company leading the development and marketing of novel therapeutics for antibody-mediated autoimmune diseases, such as lupus and ant…

Articles about LaJolla Pharmaceutical Company's IPO: